insulin sec analysis - sepax technologies, inc. · insulin sec analysis •insulin samples:...

12
Insulin SEC analysis Insulin Samples: Lispro, identical in structure to Insulin Human, except that it has lysine and proline at positions 28 and 29, respectively, of chain B, whereas this sequence is reversed in Insulin Human. Sigma human recombinant insulin, P/N 910776 Custom insulin sample for column life time study Degraded insulin sample (40 hours at 60 o C) www.sepax-tech.com Better Surface Chemistry for Better Separation © Sepax Technologies, Inc. EE1004

Upload: duongdung

Post on 12-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Insulin SEC Analysis - Sepax Technologies, Inc. · Insulin SEC analysis •Insulin Samples: –Lispro, identical in structure to Insulin Human, except that it has lysine and prolineat

Insulin SEC analysis

• Insulin Samples:– Lispro, identical in structure to Insulin Human,

except that it has lysine and proline at positions 28 and 29, respectively, of chain B, whereas this sequence is reversed in Insulin Human.

– Sigma human recombinant insulin, P/N 910776 – Custom insulin sample for column life time study– Degraded insulin sample (40 hours at 60 oC)

www.sepax-tech.comBetter Surface Chemistry for Better Separation © Sepax Technologies, Inc.

EE1004

Page 2: Insulin SEC Analysis - Sepax Technologies, Inc. · Insulin SEC analysis •Insulin Samples: –Lispro, identical in structure to Insulin Human, except that it has lysine and prolineat

Insulin-Lispro (Humalog)-mobile phase effect on ZenixTM-C SEC-80 ( 7830 )

www.sepax-tech.comBetter Surface Chemistry for Better Separation © Sepax Technologies, Inc.

Column: ZenixTM-C SEC-80 (3 µm, 80 Å, 7.8 x 300 mm) Mobile phase: as indicated, Flow rate: 1 mL/minDetector: UV 276 nm, Column temperature: 30 ℃, Injection volume: 10 µLSample: Insulin Lispro 3.47 mg/mL in phosphate buffer containing m-cresol

min0 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0

250

500

750

1000

1250

1500

1750

2000

2250

1

1

1

22

2

A

B

C

A. 0.1% TFA, 50% ACNB. 0.1% Arginine:Acetonitrile:Acetic acid

(65:20:15)A. 10 mM Tris, 140 mM NaCl, pH 7.4

1. Insulin monomer2. M-cresol

Organic mobile phase minimizes the interaction between sample and column resin.

EE1004

Page 3: Insulin SEC Analysis - Sepax Technologies, Inc. · Insulin SEC analysis •Insulin Samples: –Lispro, identical in structure to Insulin Human, except that it has lysine and prolineat

Zoom in-Insulin Lispro (monomer and aggregate)

www.sepax-tech.comBetter Surface Chemistry for Better Separation © Sepax Technologies, Inc.

min4 5 6 7 8 9 10 11 12 13

mAU

0

2

4

6

8

10

12

min4 5 6 7 8 9 10 11 12 13

mAU

0

2

4

6

8

10

12

14

min4 5 6 7 8 9 10 11 12 13

mAU

0

2

4

6

8

10

12

Rs = 2.11

Rs = 3.28

Rs = 3.26 0.1% TFA, 50% ACN

0.1% Arginine:Acetonitrile:Acetic acid (65:20:15)

10 mM Tris, 140 mM NaCl, pH 7.4

EE1004

Page 4: Insulin SEC Analysis - Sepax Technologies, Inc. · Insulin SEC analysis •Insulin Samples: –Lispro, identical in structure to Insulin Human, except that it has lysine and prolineat

Column temperature- insulin Lispro

www.sepax-tech.comBetter Surface Chemistry for Better Separation © Sepax Technologies, Inc.

Column: ZenixTM-C SEC-80 (3 µm, 80 Å, 7.8 x 300 mm) Mobile phase: 0.1% Arginine:Acetonitrile:Acetic acid (65:20:15), Flow rate: 0.5 mL/min, Pressure: 38 barDetector: UV 276 nm, Column temperature: 37 ℃ and 30 ℃, Injection volume: 10 µL, Sample: Insulin Lispro 3.47 mg/mL in phosphate containing m-cresol

min0 5 10 15 20 25 30 35

mAU

0

200

400

600

800

1000

1200

1400

1600 30 ℃37 ℃

Insulin monomer

M-cresol

EE1004

Page 5: Insulin SEC Analysis - Sepax Technologies, Inc. · Insulin SEC analysis •Insulin Samples: –Lispro, identical in structure to Insulin Human, except that it has lysine and prolineat

Pore size effect-insulin Lispro

www.sepax-tech.comBetter Surface Chemistry for Better Separation © Sepax Technologies, Inc.

Column: ZenixTM-C SEC-80 (3 µm, 80 Å, 7.8 x 300 mm), Pressure: 103 bar ZenixTM-C SEC-150 (3 µm, 150 Å, 7.8 x 300 mm), Pressure: 103 bar

Mobile phase: 0.1% Arginine:Acetonitrile:Acetic acid (65:20:15), Flow rate: 1 mL/min,Detector: UV 276 nm, Column temperature: 37 ℃ and 30 ℃, Injection volume: 10 µL, Sample: Insulin Lispro 3.47 mg/mL in phosphate containing m-cresol

ZenixTM-C SEC-80 provides a better resolution for insulin aggregate and monomer serparation.

min0 2 4 6 8 10 12 14 16

mAU

0

250

500

750

1000

1250

1500

1750

2000

min6 7 8 9 10 11 12

mAU

0

1

2

3

4

5

6

7

ZenixTM-C SEC-80ZenixTM-C SEC-150

Zoom in

Rs = 3.28

Rs = 2.14

M-cresol

EE1004

Page 6: Insulin SEC Analysis - Sepax Technologies, Inc. · Insulin SEC analysis •Insulin Samples: –Lispro, identical in structure to Insulin Human, except that it has lysine and prolineat

Column size effect – Insulin Lispro

min2 4 6 8 10 12

mAU

0

2

4

6

8

10

12

min2 4 6 8 10 12

mAU

-1

0

1

2

3

4

5

6

7

Column: ZenixTM-C SEC-80 (3 µm, 80 Å, 4.6 x 300 mm), Flow rate: 0.35 mL/min, Injection volume: 5 µLZenixTM-C SEC-80 (3 µm, 80 Å, 7.8 x 300 mm), Flow rate: 1 mL/min, Injection volume: 10 µL

Mobile phase: 0.1% Arginine:Acetonitrile:Acetic acid (65:20:15)Detector: UV 276 nm, Column temperature: 30 ℃Sample: Insulin Lispro 3.47 mg/mL in phosphate buffer containing m-cresol

www.sepax-tech.comBetter Surface Chemistry for Better Separation © Sepax Technologies, Inc.

Rs = 2.79

Rs = 3.28

7.8 x 300 mm

4.6 x 300 mm

EE1004

Page 7: Insulin SEC Analysis - Sepax Technologies, Inc. · Insulin SEC analysis •Insulin Samples: –Lispro, identical in structure to Insulin Human, except that it has lysine and prolineat

Flow rate effect- insulin Lispro

www.sepax-tech.comBetter Surface Chemistry for Better Separation © Sepax Technologies, Inc.

Column: ZenixTM-C SEC-80 (3 µm, 80 Å, 7.8 x 300 mm) Mobile phase: 0.1% Arginine:Acetonitrile:Acetic acid (65:20:15), Flow rate: 0.5 and 1 mL/minDetector: UV 276 nm, Column temperature: 30 ℃, Injection volume: 10 µL, Sample: Insulin Lispro 3.47 mg/mL in phosphate containing m-cresol

min5 10 15 20 25 30 35

mAU

-2

0

2

4

6

min4 6 8 10 12 14 16

mAU

-2

0

2

4

0.5 mL/min

1 mL/min

Rs=3.84

Rs = 3.39

Slower flow rate gives slightly better resolution at the expense of analysis speed.

EE1004

Page 8: Insulin SEC Analysis - Sepax Technologies, Inc. · Insulin SEC analysis •Insulin Samples: –Lispro, identical in structure to Insulin Human, except that it has lysine and prolineat

Duplicate injections of insulin Lispro

www.sepax-tech.comBetter Surface Chemistry for Better Separation © Sepax Technologies, Inc.

Column: ZenixTM-C SEC-80 (3 µm, 80 Å, 7.8 x 300 mm) Mobile phase: 0.1% Arginine:Acetonitrile:Acetic acid (65:20:15), Flow rate: 1 mL/min, Pressure: 103 barDetector: UV 276 nm, Column temperature: 30 ℃, Injection volume: 10 µLSample: Insulin Lispro 3.47 mg/mL in phosphate containing m-cresol

min0 2 4 6 8 10 12 14 16

mAU

0

250

500

750

1000

1250

1500

1750

Insulin

M-cresolHigh run to run reproducibility

EE1004

Page 9: Insulin SEC Analysis - Sepax Technologies, Inc. · Insulin SEC analysis •Insulin Samples: –Lispro, identical in structure to Insulin Human, except that it has lysine and prolineat

Degraded insulin on ZenixTM-C SEC-80

www.sepax-tech.comBetter Surface Chemistry for Better Separation © Sepax Technologies, Inc.

Column: ZenixTM-C SEC-80 (3 µm, 80 Å, 7.8 x 300 mm) Mobile phase: 0.1% TFA, 50% acetonitrile, Flow rate: 1 mL/min, Pressure: 75 barDetector: UV 276 nm, Column temperature: 30 ℃, Injection volume: 10 µL, Sample: Degraded insulin 3.75 mg/mL in phosphate buffer containing m-cresol (40 hours at 60 oC)

min4 5 6 7 8 9 10 11

mAU

0

20

40

60

80

100

6.087

6.802

7.056

min0 2 4 6 8 10 12 14 16

mAU

0

250

500

750

1000

1250

1500

1750

2000

M-cresol

Insulin

EE1004

Page 10: Insulin SEC Analysis - Sepax Technologies, Inc. · Insulin SEC analysis •Insulin Samples: –Lispro, identical in structure to Insulin Human, except that it has lysine and prolineat

Insulin Analysis on ZenixTM-C SEC-80 ( 4630 )

www.sepax-tech.comBetter Surface Chemistry for Better Separation © Sepax Technologies, Inc.

Column: ZenixTM-C SEC-80 (3 µm, 80 Å, 4.6 x 300 mm) Mobile phase0.1% Arginine:Acetonitrile:Acetic acid (65:20:15), Flow rate: 0.35 mL/min,Detector: UV 276 nm, Column temperature: 30 ℃, Injection volume: 5 µL, Pressure: 90 bar,Sample: Insulin Lispro 3.47 mg/mL in phosphate buffer containing m-cresol, sigma insulin 3.8 mg/mL in 0.01 N HCl containing phenol and m-cresol

min0 2 4 6 8 10 12 14 16 18

mAU

0

250

500

750

1000

1250

1500

1750m-cresol

phenolmin2 4 6 8 10 12

mAU

5

10

15

20

25

30

Zoom in

Lispro

Sigma

EE1004

Page 11: Insulin SEC Analysis - Sepax Technologies, Inc. · Insulin SEC analysis •Insulin Samples: –Lispro, identical in structure to Insulin Human, except that it has lysine and prolineat

Column: ZenixTM-C SEC-80 ( 3 µm, 80 Å, 7.8 x 300 mm) Mobile phase: 0.1% Arginine : ACN : HAc = 65 : 20 : 15 ( v/v ), Flow rate: 0.5 mL/minDetector: UV 276 nm, Column temperature: 40 ℃, Injection volume: 25 µLSample: Insulin 4 mg/mL in 0.01 N HCl, Pressure: 52 bar

Life time testInsulin Analysis on ZenixTM-C SEC-80 ( 7830 )

www.sepax-tech.comBetter Surface Chemistry for Better Separation © Sepax Technologies, Inc.

min0 2.5 5 7.5 10 12.5 15 17.5 20 22.5

mAU

0

50

100

150

200

250

300

Injection 1Injection 50Injection 100Injection 150

Injection 200

Aggregate

Insulin monomer

EE1004

Page 12: Insulin SEC Analysis - Sepax Technologies, Inc. · Insulin SEC analysis •Insulin Samples: –Lispro, identical in structure to Insulin Human, except that it has lysine and prolineat

Insulin analysis parameters-life time test

injection RT Plates Tailing Rs Area% dimer

1 16.08 19767 0.79 4.32 3.37

50 16.13 20116 0.79 4.43 3.21

100 16.17 20327 0.8 4.44 3.18

150 16.22 21287 0.82 4.42 3.34

200 16.28 21629 0.83 4.44 3.15

RSD/% 0.48 3.86 2.25 1.16 3.04

www.sepax-tech.comBetter Surface Chemistry for Better Separation © Sepax Technologies, Inc.

EE1004